ArticlePLOS global public health2025
Etiology of asymptomatic bacteriuria, antimicrobial susceptibility patterns and associated risk factors among pregnant women attending antenatal clinic in western Kenya.
Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Prevalence of Asymptomatic Bacteriuria Among Jordanian Pregnant Women.International journal of women's health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Approximately 11.1% of pregnant women in Africa experience asymptomatic bacteriuria (ASB), and its proper understanding is critical due to its risks, including pyelonephritis in mothers and fetal mortality. However, a significant gap remains in understanding the optimal screening and treatment protocols for ASB in pregnant women. We assessed the etiology of asymptomatic bacteriuria, antimicrobial susceptibility patterns, and associated risk factors among pregnant women attending an antenatal clinic in western Kenya. Using a cross-sectional quantitative design, 285 asymptomatic pregnant women were recruited, interviewed using a questionnaire and provided urine for culture. Microbial susceptibility was tested using the Kirby Bauer disk diffusion technique and interpreted based on the Clinical and Laboratory Standards Institute guidelines. Asymptomatic bacteriuria prevalence was 16.3% (44/270), and increased with gestational age for trimester 1, 2 and 3 at 12%, 17.7% and 19.3%, respectively. Of the ASB cases, 45.5% (20/44) were caused by gram-negative bacteria, and 56.8% (25/44) by gram-positive bacteria. Isolated gram-negative bacteria were Escherichia coli (80%), Klebsiella pneumoniae (10%), Proteus mirabilis (5%) and Pseudomonas aeruginosa (5%), while the isolated gram-positive bacteria were coagulase-negative Staphylococcus species (52%), Enterococcus species (20%), Staphylococcus aureus (16%) and Streptococcus agalactiae (8%). Antibiotics with high sensitivity by gram-negative bacteria were azithromycin, meropenem, and tobramycin (100% susceptibility), while all isolates (100%) were resistant to trimethoprim-sulfamethoxazole. Gram-positive isolates were highly (100%) sensitive to gentamicin, ofloxacin, clindamycin and ampicillin, and 56% were resistant to trimethoprim-sulfamethoxazole. Women with at least a secondary school education had 2.47 times higher odds of getting asymptomatic bacteriuria (AOR = 2.47, 95% CI [1.09, 5.98], p = 0.036), while women between 25-34 years of age were at 2.23 times higher odds of ASB (AOR = 2.23, 95% CI [1.07, 4.63], p = 0.030). There is a need for extensive antimicrobial susceptibility testing to identify safe and effective antibiotics for treating ASB.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.